What is the main business of Me.Cro?

The main business activity of Me.Cro focuses on research and experimental development on biotechnology.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on March 17, 2022.

Where is the headquarters located?

The headquarters is located at: ul. Hurtowa 4, 15-399 Białystok.

Who is on the management board?

The management board consists of: Maciej Szamborski (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 100,000 (approx. $27,012).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2023 to December 31, 2023.

How much revenue was generated?

The company reported a revenue of $890 in 2023, which is an increase of 199925.1% compared to 2022.

No, the company recorded a net loss of $4,081 in 2023. For comparison, in 2022 the loss was $4,431, meaning the company reduced its loss by 13.2%.

Me.CroS.A.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2022-03-17

Share capital

100 000,00 PLN

Registered address

ul. Hurtowa 4/7, 15-399 Białystok, Poland

Website

me-cro.com

Electronic delivery address

AE:PL-78219-81551-SGSCC-36

Financials

The financial statement for 2024 has not yet been filed with the Financial Document Repository (past deadline).

Revenue history

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2023.

Results vs industry

Revenue

This companyUSD 890.14MedianUSD 38.31kAverageUSD 2.31m

Net profit

This companyUSD -4.08kMedianUSD -1.50kAverageUSD -84.98k

Operating costs

This companyUSD 4.96kMedianUSD 56.25kAverageUSD 2.29m

Assets

This companyUSD 15.40kMedianUSD 116.77kAverageUSD 2.72m

Industry

Bank accounts

Registered as a VAT taxpayer on 2022-05-01. Active

Erste Bank Polska
22 1090 2590 0000 0001 4934 6233
Erste Bank Polska
92 1090 2590 0000 0001 4934 6234

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

No public aid cases recorded in the last 10 years.

Tenders

No recorded participation in tenders.

Regulatory authorisations

Authority	Type	Status
BDO	BDO register entry	Active

Authorized Representatives

Maciej Szamborski — President of the Management Board

Manner of representation

In the case of a one-person management board – the member of the management board independently. In the case of a multi-member management board – joint action by two members of the management board, or by one member of the management board jointly with a commercial proxy.

Supervisory board

Beata Szukajt — Supervisory Board Member

Mariusz Grotek — Supervisory Board Member

Monika Szamborska — Supervisory Board Member

Ownership

Owner	Shares	Share value	Stake
Galaktus sp. z o.o.	100,000	$27,012.43	100%

Beneficial owners

Person	Rights
Maciej Szamborski (35)	W związku z brakiem beneficjenta rzeczywistego wynikającego z beśpośrednich i pośrednich uprawnień właścicielskich wskazano prezesa zarządu

Competitors

Name	Revenue	Website
InventroS.A.	$12,176.61	inventro.co
Plan Biosp. z o.o.	$3,404.49	biotrem.pl
Passio Human Microbiomesp. z o.o.	$1,856.58	passiohumanmicrobiome.com
Dairy Biotechnologiessp. z o.o.	$1,485.09	milcu.eu
Medical Algorithmssp. z o.o.	$682.08	medicalalgorithms.eu
Centrum Transferu Technologii Meditransfer Iitdsp. z o.o.	$228.56	iitd.pan.wroc.pl
Fungotechsp. z o.o.	$187.68	fungo.tech
Wavex Energysp. z o.o.	$142.33	wavexenergy.com
Ncage TherapeuticsS.A.	$29.14	ncage.org
Innervisionsp. z o.o.	$4.54	innervision.pl

FAQ

Last updated: 2026-04-12